|
 |
|
Endeavour |
| This multi-specialty division is responsible for the Anti-infective and Cephalosporin business for Lupin. It focuses on acute therapy areas with a product portfolio comprising Antibiotics, Pain management, Gastrointestinal and Anti-Osteoporosis products. The Endeavour team networks with leading Physicians, General Surgeons, General Practitioners, ENT, Gyneacologists and Paediatricians. Lupin grew at an outstanding rate of 20% in the GI space in FY 2010. Lupin's Anti-infective business in India grew by 15% in the same timeframe. Endeavour made a strategic entry into the anti-arthritic segment with the launch of its first in-licensed brand Hyalgan for Osteoarthritis.
Key Products : Endeavour
|
Product |
Therapeutic segment
|
Product Rank in the relevant segment |
|
Softovac |
Bulk Producers |
2 |
|
Cefaxone |
Ceftriaxone Injectible |
4 |
|
Doxcef |
Cefpodoxime Solids |
4 |
|
Signoflam |
Other Aceclofenac Comb. |
4 |
| |
